Literature DB >> 24125558

Development of a high-resolution fat and CSF-suppressed optic nerve DTI protocol at 3T: application in multiple sclerosis.

R S Samson, M Kolappan, D L Thomas, M R Symms, P Connick, D H Miller, Claudia A M Wheeler-Kingshott.   

Abstract

Clinical trials of neuroprotective interventions in multiple sclerosis require outcome measures that reflect the disease pathology. Measures of neuroaxonal integrity in the anterior visual pathways are of particular interest in this context, however imaging of the optic nerve is technically challenging. We therefore developed a 3T optic nerve diffusion tensor imaging protocol incorporating fat and cerebrospinal fluid suppression and without parallel imaging. The sequence used a scheme with six diffusion-weighted directions, b = 600 smm(-2) plus one b ≈ 0 (b(0)) and 40 repetitions, averaged offline, giving an overall scan time of 30 minutes. A coronal oblique orientation was used with voxel size 1.17 mm x 1.17 mm x 4 mm, We validated the sequence in 10 MS patients with a history of optic neuritis and 11 healthy controls: mean fractional anisotropy was reduced in the patients: 0.346(±0.159) versus 0.528(±0.123), p<0.001; radial diffusivity was increased: 0.940(±0.370)x10(-6) mm(2) s(-1) compared to 0.670(± 0.221)x10(-6) mm(2) s(-1) (p<0.01). No significant differences were seen for mean diffusivity or mean axial diffusivity.

Entities:  

Mesh:

Year:  2013        PMID: 24125558      PMCID: PMC3812733          DOI: 10.11138/FNeur/2013.28.2.093

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  26 in total

1.  Distortion-free diffusion tensor imaging of cranial nerves and of inferior temporal and orbitofrontal white matter.

Authors:  M A Koch; V Glauche; J Finsterbusch; U G Nolte; J Frahm; C Weiller; C Büchel
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

2.  How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging.

Authors:  Jesper L R Andersson; Stefan Skare; John Ashburner
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

3.  Generalized autocalibrating partially parallel acquisitions (GRAPPA).

Authors:  Mark A Griswold; Peter M Jakob; Robin M Heidemann; Mathias Nittka; Vladimir Jellus; Jianmin Wang; Berthold Kiefer; Axel Haase
Journal:  Magn Reson Med       Date:  2002-06       Impact factor: 4.668

4.  The use of power images to perform quantitative analysis on low SNR MR images.

Authors:  A J Miller; P M Joseph
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

5.  Diffusion tensor imaging of the optic nerve in multiple sclerosis: association with retinal damage and visual disability.

Authors:  S A Smith; Z R Williams; J N Ratchford; S D Newsome; S K Farrell; J A D Farrell; A Gifford; N R Miller; P C M van Zijl; P A Calabresi; D S Reich
Journal:  AJNR Am J Neuroradiol       Date:  2011-07-28       Impact factor: 3.825

6.  The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

Authors:  B D Youl; G Turano; D H Miller; A D Towell; D G MacManus; S G Moore; S J Jones; G Barrett; B E Kendall; I F Moseley
Journal:  Brain       Date:  1991-12       Impact factor: 13.501

7.  Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis.

Authors:  Simon J Hickman; Claudia A M Wheeler-Kingshott; Stephen J Jones; Katherine A Miszkiel; Gareth J Barker; Gordon T Plant; David H Miller
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

8.  ADC mapping of the human optic nerve: increased resolution, coverage, and reliability with CSF-suppressed ZOOM-EPI.

Authors:  Claudia A M Wheeler-Kingshott; Geoffrey J M Parker; Mark R Symms; Simon J Hickman; Paul S Tofts; David H Miller; Gareth J Barker
Journal:  Magn Reson Med       Date:  2002-01       Impact factor: 4.668

9.  Nonlinear smoothing for reduction of systematic and random errors in diffusion tensor imaging.

Authors:  G J Parker; J A Schnabel; M R Symms; D J Werring; G J Barker
Journal:  J Magn Reson Imaging       Date:  2000-06       Impact factor: 4.813

Review 10.  Diffusion-weighted imaging of the spinal cord and optic nerve.

Authors:  G J Barker
Journal:  J Neurol Sci       Date:  2001-05-01       Impact factor: 3.181

View more
  6 in total

1.  Role of coronal high-resolution diffusion-weighted imaging in acute optic neuritis: a comparison with axial orientation.

Authors:  Ping Lu; Yan Sha; Hailin Wan; Feng Wang; Guohong Tian
Journal:  Neuroradiology       Date:  2017-06-24       Impact factor: 2.804

2.  Fractional anisotropy helps to differentiate the optic nerve impairment between neuromyelitis optica spectrum disorders and multiple sclerosis.

Authors:  Yan Xie; Yan Zhang; Yihao Yao; Dong Liu; Bo Chen; Wenzhen Zhu
Journal:  Eur Radiol       Date:  2022-04-14       Impact factor: 7.034

Review 3.  Vision and vision-related outcome measures in multiple sclerosis.

Authors:  Laura J Balcer; David H Miller; Stephen C Reingold; Jeffrey A Cohen
Journal:  Brain       Date:  2014-11-28       Impact factor: 13.501

Review 4.  Imaging outcomes for trials of remyelination in multiple sclerosis.

Authors:  Shahrukh Mallik; Rebecca S Samson; Claudia A M Wheeler-Kingshott; David H Miller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-25       Impact factor: 10.154

5.  MRI-derived diffusion parameters in the human optic nerve and its surrounding sheath during head-down tilt.

Authors:  Darius A Gerlach; Karina Marshall-Goebel; Khader M Hasan; Larry A Kramer; Noam Alperin; Joern Rittweger
Journal:  NPJ Microgravity       Date:  2017-06-21       Impact factor: 4.415

6.  The Evaluation of Optic Nerves Using 7 Tesla "Silent" Zero Echo Time Imaging in Patients with Leber's Hereditary Optic Neuropathy with or without Idebenone Treatment.

Authors:  Cezary Grochowski; Mark Symms; Kamil Jonak; Paweł Krukow; Tobias Wood; Emil Ljungberg; Joaquim Enseñat; Katarzyna Nowomiejska; Robert Rejdak; Ryszard Maciejewski; Gareth J Barker
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.